Amgen Financial Statements From 2010 to 2026

Stocks . Germany . 
Stock . Amgen Inc
AMG Stock  EUR 329.30  11.55  3.63%   
Amgen's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Amgen's valuation are provided below:
Market Capitalization
105.2 B
Enterprise Value Revenue
6.8748
There are over sixty-two available fundamental signals for Amgen Inc, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to validate Amgen's prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road.

Amgen Total Revenue

29.59 Billion

Check Amgen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen's main balance sheet or income statement drivers, such as Tax Provision of 1.4 B, Interest Income of 218.9 M or Interest Expense of 1.7 B, as well as many indicators such as . Amgen financial statements analysis is a perfect complement when working with Amgen Valuation or Volatility modules.
  
This module can also supplement various Amgen Technical models . Check out the analysis of Amgen Correlation against competitors.

Amgen Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets82.8 B90.6 B76.5 B
Pretty Stable
Total Current Liabilities16.8 B25.5 B13.9 B
Slightly volatile
Total Stockholder Equity9.4 B8.7 B18 B
Slightly volatile
Accounts Payable1.7 B2.4 B1.3 B
Slightly volatile
Cash8.1 B9.1 B6 B
Slightly volatile
Non Current Assets Total49.5 B61.5 B40.5 B
Slightly volatile
Non Currrent Assets Other6.4 B12.7 B4.4 B
Slightly volatile
Long Term Debt43.3 B50 B36.4 B
Slightly volatile
Net Receivables5.8 B9.6 B4.6 B
Slightly volatile
Good Will17.6 B18.7 B15.7 B
Slightly volatile
Non Current Liabilities Total53 B56.4 B44.3 B
Slightly volatile
Inventory5.3 B6.2 B4.1 B
Slightly volatile
Other Current Assets1 B1.2 B1.5 B
Slightly volatile
Total Liabilities69.8 B81.9 B58.3 B
Slightly volatile
Short and Long Term Debt4.8 B4.6 B3.3 B
Slightly volatile
Total Current Assets24.2 B29.1 B35.5 B
Slightly volatile
Non Current Liabilities Other2.2 B2.4 B1.8 B
Slightly volatile
Short Term Debt2.6 B2.7 B3.5 B
Slightly volatile
Intangible Assets19.4 B22.3 B15.1 B
Slightly volatile
Net Debt38.3 B45.5 B33.7 B
Slightly volatile
Common Stock Shares Outstanding464.4 M538.8 M632 M
Slightly volatile
Net Invested Capital57.6 B63.3 B56.1 B
Pretty Stable
Net Working Capital3.4 B3.6 B23.6 B
Slightly volatile
Capital Stock35.7 B34 B32.1 B
Slightly volatile
Property Plant And Equipment Net6.4 B7.9 B5.4 B
Slightly volatile
Property Plant And Equipment Gross16.9 B19 B14.4 B
Slightly volatile

Amgen Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision1.4 B1.3 B1.6 B
Pretty Stable
Interest Income218.9 M230.4 M499.3 M
Slightly volatile
Selling General Administrative6.3 B7 B5.5 B
Slightly volatile
Total Revenue29.6 B36.8 B25.7 B
Slightly volatile
Gross Profit22 B24.7 B19.7 B
Slightly volatile
Operating Income7.2 B9.1 B9.2 B
Slightly volatile
Net Income From Continuing Ops7.1 B7.7 B6.9 B
Slightly volatile
EBIT14.1 B14.9 B12.9 B
Slightly volatile
Research Development5.3 B7.3 B4.5 B
Slightly volatile
Cost Of Revenue7.6 B12 B6 B
Slightly volatile
Total Operating Expenses19.7 B27.7 B16.3 B
Slightly volatile
Income Before Tax6.5 B9 B8.4 B
Slightly volatile
Net Income7.1 B7.7 B6.9 B
Slightly volatile
EBITDA8.6 B7.9 B11.1 B
Slightly volatile
Reconciled Depreciation3.8 B5.2 B2.9 B
Slightly volatile

Amgen Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation3.7 B5.2 B2.9 B
Slightly volatile
Capital Expenditures1 B1.9 B905.7 M
Slightly volatile
Total Cash From Operating Activities8.1 B10 B10.1 B
Slightly volatile
Net Income7.1 B7.7 B6.9 B
Slightly volatile
End Period Cash Flow8.1 B9.1 B6 B
Slightly volatile
Free Cash Flow7.3 B8.1 B9.6 B
Slightly volatile
Begin Period Cash Flow7.9 B12 B5.6 B
Slightly volatile
Stock Based Compensation445.5 M494 M356 M
Slightly volatile

Amgen Fundamental Market Drivers

About Amgen Financial Statements

Amgen investors utilize fundamental indicators, such as revenue or net income, to predict how Amgen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue36.8 B29.6 B
Cost Of Revenue12 B7.6 B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
How To Invest In Amgen
Details
Is Amgen Stock a good investment?
Details
What is Amgen's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Amgen Correlation against competitors.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Understanding that Amgen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Amgen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Amgen's market price signifies the transaction level at which participants voluntarily complete trades.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY